Overcome common hurdles in scaling up mRNA-based therapeutics
“At GeneLeap, we focus on utilizing mRNA for vaccine development, drug discovery, and lipid nanoparticle delivery technology platforms. Our vision is to redefine the possibilities in healthcare by looking beyond traditional therapies. We develop synthetic, modified mRNA drugs with the capability to encode a wide range of natural and engineered proteins designed to be absorbed by specific cells in designated tissues or organs. This mechanism focuses on diseases where targeted cell activation can significantly aid the body in combating or preventing various health conditions.” - Xinyue (Frank) Zhang, Manager of mRNA Process Development at GeneLeap Biotechnolog
Read article